UBS Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $36.7M | Buy |
|
|||||
|
2025
Q2 | $24.3M | Sell |
|
|||||
|
2025
Q1 | $16.2M | Buy |
|
|||||
|
2024
Q4 | $18.9M | Buy |
|
|||||
|
2024
Q3 | $10.3M | Buy |
|
|||||
|
2024
Q2 | $6.28M | Sell |
|
|||||
|
2024
Q1 | $11.9M | Sell |
|
|||||
|
2023
Q4 | $7.65M | Buy |
|
|||||
|
2023
Q3 | $2.26M | Sell |
|
|||||
|
2023
Q2 | $5.53M | Buy |
|
|||||
|
2023
Q1 | $5.49M | Sell |
|
|||||
|
2022
Q4 | $5.06M | Buy |
|
|||||
|
2022
Q3 | $1.08M | Sell |
|
|||||
|
2022
Q2 | $2.19M | Sell |
|
|||||
|
2022
Q1 | $5.76M | Buy |
|
|||||
|
2021
Q4 | $4.39M | Buy |
|
|||||
|
2021
Q3 | $778K | Sell |
|
|||||
|
2021
Q2 | $1.29M | Buy |
|
|||||
|
2021
Q1 | $989K | Buy |
|
|||||
|
2020
Q4 | $224K | Buy |
|
|||||
|
2020
Q3 | $7K | Buy |
|